NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

The amount of Burrill's investment is not being disclosed by the Bangalore, India-based bioinformatics firm. However, Strand noted that the financing included both a primary investment into the firm and a secondary buy-out of the lead investors from its Series A round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.